Rank 48 • Biotech & Discovery
EvolutionaryScale
Develops generative biology foundation models to design novel proteins and accelerate life science discovery.
Visit website- Signal Score
- 87.5
- Total raised
- $142M
- Stage
- Series A
- Founded
- 2023
- Headquarters
- New York, USA
- Region
- North America
Their signal
Backed by a massive seed round, EvolutionaryScale's ESM3 model represents a major leap forward in biological foundation models, allowing researchers to program and generate entirely new biological constructs.
Signal Score 87.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.